Dai, J.; Zhang, Y.; Gao, Y.; Bai, X.; Liu, F.; Li, S.; Yu, Y.; Hu, W.; Shi, T.; Shi, D.;
et al. Toward a Treatment of Cancer: Design and In Vitro/In Vivo Evaluation of Uncharged Pyrazoline Derivatives as a Series of Novel SHP2 Inhibitors. Int. J. Mol. Sci. 2022, 23, 3497.
https://doi.org/10.3390/ijms23073497
AMA Style
Dai J, Zhang Y, Gao Y, Bai X, Liu F, Li S, Yu Y, Hu W, Shi T, Shi D,
et al. Toward a Treatment of Cancer: Design and In Vitro/In Vivo Evaluation of Uncharged Pyrazoline Derivatives as a Series of Novel SHP2 Inhibitors. International Journal of Molecular Sciences. 2022; 23(7):3497.
https://doi.org/10.3390/ijms23073497
Chicago/Turabian Style
Dai, Jiajia, Yiting Zhang, Yanan Gao, Xiaoyi Bai, Fang Liu, Shuo Li, Yanyan Yu, Wenpeng Hu, Ting Shi, Dayong Shi,
and et al. 2022. "Toward a Treatment of Cancer: Design and In Vitro/In Vivo Evaluation of Uncharged Pyrazoline Derivatives as a Series of Novel SHP2 Inhibitors" International Journal of Molecular Sciences 23, no. 7: 3497.
https://doi.org/10.3390/ijms23073497
APA Style
Dai, J., Zhang, Y., Gao, Y., Bai, X., Liu, F., Li, S., Yu, Y., Hu, W., Shi, T., Shi, D., & Li, X.
(2022). Toward a Treatment of Cancer: Design and In Vitro/In Vivo Evaluation of Uncharged Pyrazoline Derivatives as a Series of Novel SHP2 Inhibitors. International Journal of Molecular Sciences, 23(7), 3497.
https://doi.org/10.3390/ijms23073497
